Stevanato Group SpA
STVN25.090USD
-0.030-0.12%
Trading geöffnet （ET）Kurse um 15 Minuten verzögert
6.85BMarktkapitalisierung
54.57KGV TTM
mehr Informationen über Stevanato Group SpA Unternehmen
Stevanato Group SpA is an Italy-based manufacturer and distributor engaged in two segments: Biopharmaceutical and Diagnostic Solutions and Engineering, including the production and distribution of drug containment solutions, drug delivery systems, and diagnostic solutions in the pharmaceutical industry. The Company delivers products, processes, and services across all stages of drug developments, including pre-clinical, clinical, and commercialization. Its Engineering segment includes the equipment and technologies developed and provided to support the end-to-end pharmaceutical, biotechnology, and diagnostic manufacturing processes. The Company operates locally, in Europe, and globally, including Brazil, China, Mexico, and the United States.
Unternehmensinformationen
BörsenkürzelSTVN
Name des UnternehmensStevanato Group SpA
IPO-datumJul 16, 2021
CEOMr. Franco Stevanato
Anzahl der mitarbeiter5521
WertpapierartOrdinary Share
GeschäftsjahresendeJul 16
AddressePiombino Dese (Pd) Via Molinella, 17
StadtPIOMBINO DESE
BörseNYSE Consolidated
LandItaly
Postleitzahl35017
Telefon390499318173
Websitehttps://www.stevanatogroup.com/
BörsenkürzelSTVN
IPO-datumJul 16, 2021
CEOMr. Franco Stevanato
Führungskräfte
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mauro Stocchi
Mr. Mauro Stocchi
Chief Business Officer
Chief Business Officer
415.36K
+0.60%
,
,
President - Engineering Business Unit
President - Engineering Business Unit
123.81K
+51.51%
Mr. Fabrizio Bonanni
Mr. Fabrizio Bonanni
Independent Director
Independent Director
119.70K
-18.37%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Independent Director
63.70K
+9.63%
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Independent Director
52.82K
+11.85%
Mr. Riccardo Butta
Mr. Riccardo Butta
President, Americas
President, Americas
30.13K
--
Mr. Alvise Spinazzi
Mr. Alvise Spinazzi
Director
Director
3.30K
--
Carla Costa
Carla Costa
Chief Human Resources Officer
Chief Human Resources Officer
--
--
Mr. Franco Moro
Mr. Franco Moro
Director
Director
--
--
Michele Monico
Michele Monico
President - DDS and IVD Business Unit
President - DDS and IVD Business Unit
--
--
Mehr Anzeigen
Name
Name/Position
Position
Aktienbesitz
Veränderung
Mr. Mauro Stocchi
Mr. Mauro Stocchi
Chief Business Officer
Chief Business Officer
415.36K
+0.60%
,
,
President - Engineering Business Unit
President - Engineering Business Unit
123.81K
+51.51%
Mr. Fabrizio Bonanni
Mr. Fabrizio Bonanni
Independent Director
Independent Director
119.70K
-18.37%
Mr. Madhavan (Madhu) Balachandran
Mr. Madhavan (Madhu) Balachandran
Independent Director
Independent Director
63.70K
+9.63%
Mr. William J. (Bill) Federici, CPA
Mr. William J. (Bill) Federici, CPA
Independent Director
Independent Director
52.82K
+11.85%
Mr. Riccardo Butta
Mr. Riccardo Butta
President, Americas
President, Americas
30.13K
--
Umsatzaufteilung
Währung: EURAktualisiert: Sun, Jul 6
Währung: EURAktualisiert: Sun, Jul 6
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Nach GeschäftsbereichEUR
Name
Umsatz
Anteil
Revenues from other containment and delivery solutions
110.55M
43.08%
Revenues from high-value solutions
110.30M
42.99%
Revenues from engineering
35.75M
13.93%
Nach RegionEUR
Name
Umsatz
Anteil
EMEA
155.50M
60.60%
North America
75.00M
29.23%
APAC
20.70M
8.07%
South America
5.40M
2.10%
Nach Geschäftsbereich
Nach Region
Nach GeschäftsbereichEUR
Name
Umsatz
Anteil
Revenues from other containment and delivery solutions
110.55M
43.08%
Revenues from high-value solutions
110.30M
42.99%
Revenues from engineering
35.75M
13.93%
Aktionärsstatistik
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Aktionäre
Aktionärstypen
Aktionäre
Aktionäre
Anteil
Conestoga Capital Advisors, LLC
16.38%
Neuberger Berman, LLC
9.27%
T. Rowe Price Investment Management, Inc.
7.55%
TimesSquare Capital Management, LLC
6.77%
Thrivent Asset Management, LLC
5.60%
Other
54.43%
Aktionäre
Aktionäre
Anteil
Conestoga Capital Advisors, LLC
16.38%
Neuberger Berman, LLC
9.27%
T. Rowe Price Investment Management, Inc.
7.55%
TimesSquare Capital Management, LLC
6.77%
Thrivent Asset Management, LLC
5.60%
Other
54.43%
Aktionärstypen
Aktionäre
Anteil
Investment Advisor/Hedge Fund
55.18%
Investment Advisor
50.76%
Pension Fund
2.88%
Research Firm
2.03%
Individual Investor
1.61%
Hedge Fund
1.08%
Bank and Trust
0.88%
Family Office
0.14%
Holding Company
0.07%
Institutionelle Beteiligung
Aktualisiert: Tue, Jul 1
Aktualisiert: Tue, Jul 1
Berichtszeitraum
Anzahl der Institutionen
Gehaltenen Aktien
Anteil
Veränderung
2025Q2
366
56.87M
114.65%
-13.39M
2025Q1
376
57.92M
116.77%
-13.37M
2024Q4
358
58.53M
118.10%
-12.44M
2024Q3
347
57.73M
116.49%
-11.43M
2024Q2
334
55.33M
111.66%
-5.97M
2024Q1
321
56.90M
119.64%
+12.26M
2023Q4
299
39.58M
111.81%
-6.75M
2023Q3
276
37.46M
106.70%
-5.32M
2023Q2
249
35.30M
102.65%
-7.24M
2023Q1
226
34.68M
101.53%
-8.19M
Mehr Anzeigen
Aktionärsaktivitäten
Name
Gehaltenen Aktien
Anteil
Veränderung
Änderung%
Datum
Conestoga Capital Advisors, LLC
8.19M
16.51%
+106.93K
+1.32%
Mar 31, 2025
Neuberger Berman, LLC
4.60M
9.27%
-37.83K
-0.82%
Mar 31, 2025
T. Rowe Price Investment Management, Inc.
3.74M
7.55%
+439.72K
+13.30%
Mar 31, 2025
TimesSquare Capital Management, LLC
3.36M
6.77%
+70.44K
+2.14%
Mar 31, 2025
Thrivent Asset Management, LLC
2.78M
5.6%
-8.29K
-0.30%
Dec 31, 2024
Artisan Partners Limited Partnership
2.28M
4.59%
-77.34K
-3.28%
Mar 31, 2025
Baron Capital Management, Inc.
1.85M
3.73%
+30.34K
+1.67%
Mar 31, 2025
Jackson Square Partners, LLC
1.16M
2.33%
-469.58K
-28.85%
Mar 31, 2025
Thornburg Investment Management, Inc.
1.11M
2.24%
-12.21K
-1.09%
Mar 31, 2025
Lazard Asset Management, L.L.C.
1.09M
2.2%
-61.81K
-5.36%
Mar 31, 2025
Mehr Anzeigen
Verbundene ETFs
Aktualisiert: Sat, Aug 2
Aktualisiert: Sat, Aug 2
Name
Anteil
First Trust IPOX Europe Equity Opportunities ETF
0.33%
SPDR S&P Kensho New Economies Composite ETF
0.25%
iShares Biotechnology ETF
0.13%
First Trust International Equity Opportunities ETF
0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
0%
Goldman Sachs Future Health Care Equity ETF
0%
Goldman Sachs MarketBeta International Equity ETF
0%
BNY Mellon International Equity ETF
0%
First Trust IPOX Europe Equity Opportunities ETF
Anteil0.33%
SPDR S&P Kensho New Economies Composite ETF
Anteil0.25%
iShares Biotechnology ETF
Anteil0.13%
First Trust International Equity Opportunities ETF
Anteil0%
Goldman Sachs MarketBeta Total Internatl Eqty ETF
Anteil0%
Goldman Sachs Future Health Care Equity ETF
Anteil0%
Goldman Sachs MarketBeta International Equity ETF
Anteil0%
BNY Mellon International Equity ETF
Anteil0%
Dividende
In den vergangenen 5 Jahren wurden insgesamt
53.45M
USD an Dividenden ausgeschüttet.
Datum
Dividende
Stichtag für die Aktienregistrierung
Zahltag
Ex-Dividendentag
May 31, 2024
STVN.NB Final Cash Dividend of gross EUR 0.053 paid on Jul 15, 2024 going ex on Jun 04, 2024
Jun 04, 2024
Jul 15, 2024
Jun 04, 2024
Jun 06, 2023
STVN.NB Final Cash Dividend of gross EUR 0.054 paid on Jul 17, 2023 going ex on Jun 07, 2023
Jun 06, 2023
Jul 17, 2023
Jun 07, 2023
Jun 08, 2022
STVN.NB Final Cash Dividend of gross EUR 0.051 paid on Jul 13, 2022 going ex on Jun 13, 2022
Jun 14, 2022
Jul 13, 2022
Jun 13, 2022
Aktien-Split
Datum
Art
Verhältnis
Keine Daten
Datum
Art
Verhältnis
Keine Daten
